KK

Kamleshbhai Kantilal Patel

Active Director Designated Partner DIN 11669524
DIN 11669524 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Kamleshbhai Kantilal Patel

Data last updated:

Kamleshbhai Kantilal Patel is a Designated Partner at Axious Lifesciences Llp (since 2026).

DIN 11669524
Primary Designation Designated Partner
First Appointment 17 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner17 Apr 20262026Active

Board colleagues of Kamleshbhai Kantilal Patel

NameDINCompanyDesignation
Aadit Kamleshbhai Patel09829102Axious Lifesciences LlpDesignated Partner
Krishna Pankajbhai Patel11669525Axious Lifesciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Axious Lifesciences Llp
Premium access

Shareholding and investment profile for Kamleshbhai Kantilal Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamleshbhai Kantilal Patel

Kamleshbhai Kantilal Patel currently holds 1 directorship: Axious Lifesciences Llp (Designated Partner, since 17 Apr 2026).

Kamleshbhai Kantilal Patel was first appointed on 17 Apr 2026 as Designated Partner at Axious Lifesciences Llp.

The current boards of Kamleshbhai Kantilal Patel's companies include Aadit Kamleshbhai Patel (Axious Lifesciences Llp), Krishna Pankajbhai Patel (Axious Lifesciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available